gene

MAPK11

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MAPK11: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1Connections
0Hypotheses
0Analyses
0Outgoing
1Incoming
0Experiments
0Debates

Summary

Page for MAPK11

View on Wiki →

No AI portrait yet

🧬 Gene Info
Gene SymbolMAPK11
Full NameMitogen-Activated Protein Kinase 11
AliasesMitogen-activated protein kinase 11 (p38β)
Chromosome22q12.1
Functionis a major signaling cascade activated by cellular stress and pro-inflammatory cytokines.
Molecular Weight41 kDa
PathwaysMAPK, MAPK pathway
UniProt ID[Q16643](https://www.uniprot.org/uniprot/Q16643)
GeneCardsMAPK11
Human Protein AtlasMAPK11
Environmental stressUV radiation, oxidative stress, hypoxia
Inflammatory cytokinesIL-1β, TNF-α, IL-6
Growth factorsSome growth factor signaling pathways
Pathogen-associated moleculesLPS through TLR signaling
Microglial activationControls pro-inflammatory cytokine production
Associated DiseasesAlzheimer's Disease, Parkinson's Disease, Neuroinflammation, Stroke
Known Drugs/CompoundsLosmapimod
KG Connections1 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

Wiki Pages (2)

Knowledge base pages for this entity

Canonical Page

MAPK11

gene · 820 words

MAPK11 Protein (p38β)

protein · 822 words

Pathway Diagram

graph TD
    A["MAPK11
(p38beta MAPK)"] B["Cellular Stress
Stimuli"] C["MKK3/MKK6
Kinases"] D["ATF2
Transcription Factor"] E["CREB
Transcription Factor"] F["Pro-inflammatory
Cytokines"] G["Neuronal
Apoptosis"] H["Synaptic
Dysfunction"] I["Neurodegeneration"] J["Alzheimer's
Disease"] K["Parkinson's
Disease"] L["Losmapimod
Inhibitor"] M["Oxidative
Stress"] N["Tau
Phosphorylation"] B -->|"activates"| C C -->|"phosphorylates"| A M -->|"activates"| A A -->|"phosphorylates"| D A -->|"phosphorylates"| E A -->|"promotes"| F A -->|"induces"| G A -->|"impairs"| H A -->|"phosphorylates"| N F -->|"contributes to"| I G -->|"leads to"| I H -->|"contributes to"| I N -->|"promotes"| I I -->|"manifests as"| J I -->|"manifests as"| K L -->|"inhibits"| A classDef central fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px classDef pathological fill:#3a1a1a,stroke:#ef5350,stroke-width:2px classDef regulatory fill:#2a1a3a,stroke:#ce93d8,stroke-width:2px classDef disease fill:#3a2a1a,stroke:#ffa726,stroke-width:2px classDef therapeutic fill:#1a3a2a,stroke:#81c784,stroke-width:2px class A central class F,G,H,I,M,N pathological class C,D,E regulatory class J,K disease class L therapeutic class B pathological

Outgoing (0)

TargetRelationTypeStr
No outgoing edges

Incoming (1)

SourceRelationTypeStr
Losmapimodinhibitsdrug0.90

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (0)

Scientific analyses that reference this entity

No analyses mention this entity

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (0)

Multi-agent debates referencing this entity

No debates reference this entity

Related Research

Hypotheses and analyses mentioning MAPK11 in their description or question text

No additional research found